He Wang

Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA.

Citigroup Global Markets Japan, Inc. (CGM-JP) is a wholly-owned broker/dealer subsidiary of Citigroup Japan Holdings GK, ultimately held by Citigroup, Inc. (NYSE: C) in the US. Previously known as Nikko Citigroup Ltd., the firm was founded in 1999 as a joint venture between US-based Citigroup and Nikko Securities, based in Japan. Headquartered in Tokyo, CGM-JP provides brokerage services to governmental institutions, financial institutions, multinational corporations and institutional investors. Their sales and trading, distribution and research capabilities span a broad range of asset classes, currencies, sectors and products including equities, commodities, credit, futures, foreign exchange (FX), emerging markets, G10 rates, municipals, prime finance and securitized markets.

Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China.

Sinopec Yangzi Petrochemical Co. Ltd. manufactures, processes, and sells crude oil and petroleum refined products. Its products can be used in the fields of light industry, textile, electronics, foodstuff processing, automobile, aviation, and modern agriculture. The company was founded in April, 1998 and is headquartered in Nanjing, China.

Asia Renal Care Pte Ltd. provides kidney dialysis and related services in the Asia-Pacific region. It provides hem dialysis treatments to patients who suffer from end-stage renal diseases. The firm owns and operates dialysis facilities in Taiwan, Philippines, Japan, Malaysia and Korea. The company was founded in 1997 and is headquartered in Singapore.

BASF-YPC Co. Ltd. manufactures petrochemical products, with ethylene and propylene as primary products. Its products include LDPE, EG, oxo-alcohols, acrylic acid, acrylic esters, formic acid, propionic acid, methylamine, dimethylformamide, ethylene glycol, benzene, toluene, low-density polyethylene and mixed Xylene. The company was founded in June 2005 and is headquartered in Nanjing, China.

CDP Group Ltd. is a holding company that provides human resource outsourcing services. It offers products such as payroll and benefit outsourcing, SaaS human resource-demand, shared services, recruitment, expatriate, and other value added services. The company was founded by Wayne Wang and Wei Lu on October 21, 2004, and is headquartered in Shanghai, China.

Fidelity Asia Ventures-Shanghai (FAV-Shanghai) is the Shanghai-based Asian venture and growth capital office of Fidelity International Ltd., a subsidiary of FMR LLC in the US. In addition to the Shanghai office, the firm has an office in Hong Kong. FAV-Shanghai is one of the earliest institutional investors in private Chinese growth companies and invests in the Asian information technology and healthcare sectors with a focus on China.

BMI Asia, Inc. provides business management initiatives services. The private company is based in Shanghai, China. The Chinese company was founded by Ye Sha.

BOCOM International (Asia) Ltd. (BOCOM International-Asia) is the wholly-owned investment banking subsidiary of BOCOM International Holdings Co. Ltd., itself a wholly-owned subsidiary of Bank of Communications Co., Ltd. (PK: BCMXY) in China. The firm was created in 2007 when BCOM Securities Co. Ltd., restructured and became BOCOM International Holdings Co., Ltd., establishing BOCOM International-Asia, BOCOM International Securities Ltd., and BOCOM International Asset Management Ltd. as wholly-owned subsidiaries, each specifically designed to focus on their unique businesses. Based in Hong Kong, BOCOM International-Asia is Bank of Communications Co., Ltd.'s capital market flagship, providing corporate financing as well as underwriting and M&A for corporate clients. In 2008, a representative office was established in Beijing.

The Blackstone Group (HK) Ltd. provides investment advisory services. The company is headquartered in Hon g Kong.

AsiaInfo-Linkage, Inc. provides software solutions to telecommunications carriers and cable television operators. It operates through the following businesses: Business Operation Support Systems, Business Intelligence Systems, Operating Support Systems (OSS) Package, Service and Data Applications, and Network Infrastructure Services. The Business Operation Support Systems business includes billing, customer relationship management, and partnership relationship management applications. The Business Intelligence Systems business is involved in data warehousing platforms, online analytical applications, and data mining applications. The OSS Package business includes protocol adaptor, service fulfilment, process management, inventory management, and service activation. The Service and Data Applications business involves mail centers, mobile device management, and mobile e-commerce platforms. The Network Infrastructure Services business includes network design and implementation, integrated network management, and professional maintenance and support. The company was founded on July 1, 2010 and is headquartered in Beijing, China.

Changzhou Bioregen Biological Pharmaceutical Co. Ltd. produces natural material medical products based on bioremediation technology. Its production and sales includes biomedical materials, tissue engineering and regenerative medicine, research and development for new drug formulations. The company was founded by Xiao Zheng Shu in April 2008 and is headquartered in Changzhou, China.

Part of Alibaba Group Holding Ltd., Alibaba.com China Ltd. provides software, technology, online business-to-business and e-commerce services.

Eight Roads Ventures Japan is a Private Equity/Venture Capital firm, a subsidiary of FIL Ltd. founded in 2008. Eight Roads Ventures Japan is headquartered in Tokyo.

Zhejiang Boner Medical Investment Management Co. Ltd. engages in the provision of medical services and hospital provision. The company was founded on May 24, 2012 and is headquartered in Hangzhou, China.

Sipai Beijing Network Technology Co., Ltd. engages in oncology, special diseases, medical consultation services, and disease management. The company was founded by Xu Guang Ma, Ji Li, and Da Yong Li on March 28, 2014 and is headquartered in Beijing, China.

Beijing Meizhong Airui Cancer Hospital Co., Ltd. is a third-level tumor specialist consultation hospital founded in 2017. The company is based in Beijing, China. The hospital offers a variety of tumor expert consultations and has eight major clinic centers, including lung cancer, breast, gynecological tumor, gastrointestinal tumor, hepatobiliary tumor, urinary tumor, tumor consultation, and tumor sieve recovery. Additionally, the hospital has multiple medical technical departments such as tumor radiation images, tumor pathology, tumor radiotherapy, tumor ultrasound, and tumor early screen intervention inspection.

Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA.